$34.89 -0.12 (%) Pfizer Inc - NYSE

Apr. 21, 2015 | 04:00 PM

Partner Headlines

  1. Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

    Benzinga | Apr. 21, 2015 | 08:05AM EST
  2. Global & Strategic Partners Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

    Benzinga | Apr. 20, 2015 | 08:04AM EST
  3. Teva Getting Serious About Mylan Bid, Says Report

    IBD | Apr. 17, 2015 | 15:54PM EST
  4. Can a Strong U.S. Dollar Increase or Decrease the Value of Global Currencies?

    GuruFocus | Apr. 16, 2015 | 17:19PM EST
  5. Are U.S. Investors Showing Confidence in the Stock Market?

    GuruFocus | Apr. 16, 2015 | 16:54PM EST
  6. New drug trial results positive

    IBD | Apr. 15, 2015 | 18:38PM EST
  7. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  8. Benzinga's M&A Chatter for Monday April 13, 2015

    Benzinga | Apr. 13, 2015 | 17:48PM EST
  9. Pfizer's

    IBD | Mar. 3, 2015 | 18:33PM EST
  10. Akorn Stock Goes Nuts As Buyout Strategy Pays Off

    IBD | Feb. 26, 2015 | 17:27PM EST
  11. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  12. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  13. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  14. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  15. Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range

    IBD | Feb. 19, 2015 | 17:32PM EST
  16. Hospira's Q4 Earnings Were Bright, Though Acquisition Is In The Cards

    GuruFocus | Feb. 19, 2015 | 12:06PM EST
  17. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  18. Pfizer Announces FDA Acceptance for Review of NDA for ALO-02

    Benzinga | Feb. 13, 2015 | 10:28AM EST
  19. Fast Money Picks For February 12

    Benzinga | Feb. 12, 2015 | 08:22AM EST
  20. GM, Google Lead Fast Money Picks For February 11

    Benzinga | Feb. 10, 2015 | 18:56PM EST
  21. Best Stock Pick For Long Term Investors

    GuruFocus | Feb. 10, 2015 | 14:40PM EST
  22. Stocks Open Up In Rising Trade; Qualys And Taiwan Semi Soar

    IBD | Feb. 10, 2015 | 10:36AM EST
  23. Richard Pzena's New Buys

    GuruFocus | Feb. 9, 2015 | 14:43PM EST
  24. Citi On The Impact Of Biosimilars And Losing $360 Billion In Revenues

    Benzinga | Feb. 9, 2015 | 11:13AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Feb. 9, 2015 | 09:18AM EST
  26. BMO Capital Upgrades Pfizer To Outperform

    Benzinga | Feb. 9, 2015 | 07:39AM EST
  27. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Feb. 9, 2015 | 07:21AM EST
  28. Richard Pzena's 5 New Q4 Stock Buys

    GuruFocus | Feb. 7, 2015 | 00:56AM EST
  29. Analysts Weigh in on Pfizer Following Acquisition Announcement of Hospira

    GuruFocus | Feb. 6, 2015 | 11:51AM EST
  30. CNBC's Stock Pops & Drops From February 5

    Benzinga | Feb. 6, 2015 | 06:44AM EST
  31. Pfizer Bids For Injectables

    IBD | Feb. 5, 2015 | 18:45PM EST
  32. Making Money With Charles Payne: 02/05/15

    FoxBusiness | Feb. 5, 2015 | 18:00PM EST
  33. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  34. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 17:27PM EST
  35. Stocks Close Near Session Highs, But Volume Softens

    IBD | Feb. 5, 2015 | 16:18PM EST
  36. Pfizer Runs Into Some Resistance

    Benzinga | Feb. 5, 2015 | 14:00PM EST
  37. Stocks Hold Near Day's Highs; GrubHub Surges

    IBD | Feb. 5, 2015 | 13:50PM EST
  38. Akorn Stock Is Breaking Out, In Buy Range

    IBD | Feb. 5, 2015 | 13:44PM EST
  39. Mid-Day Market Update: Hospira Jumps On Acquisition News; iRobot Shares Slide

    Benzinga | Feb. 5, 2015 | 13:09PM EST
  40. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 11:34AM EST
  41. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  42. Stocks Climb In Soft Trade; O'Reilly, Tableau Post Q4 Wins

    IBD | Feb. 5, 2015 | 10:34AM EST
  43. Benzinga's Volume Movers

    Benzinga | Feb. 5, 2015 | 10:26AM EST
  44. Stocks Hitting 52-Week Highs

    Benzinga | Feb. 5, 2015 | 10:13AM EST
  45. Morning Market Gainers

    Benzinga | Feb. 5, 2015 | 09:44AM EST
  46. Stock Futures Snub Mixed Data; Hospira Spikes, Keurig Crumbles

    IBD | Feb. 5, 2015 | 09:09AM EST
  47. Pfizer Reports FDA Acceptance For Review Of SNDA For Oral Xelja

    Benzinga | Feb. 4, 2015 | 15:23PM EST
  48. Walt Disney Co (DIS) The Magical World of Earnings, Pfizer Inc (PFE) Ibrance FDA-approved for ...

    GuruFocus | Feb. 4, 2015 | 12:08PM EST
  49. Bestinfond's Top 5 New Buys During Q4

    GuruFocus | Feb. 3, 2015 | 16:15PM EST
  50. Tax Offshore Profit 14%-19%?

    IBD | Feb. 2, 2015 | 18:46PM EST
Trading Center